136 related articles for article (PubMed ID: 29352111)
1. Hepatic SMARCA4 predicts HCC recurrence and promotes tumour cell proliferation by regulating SMAD6 expression.
Chen Z; Lu X; Jia D; Jing Y; Chen D; Wang Q; Zhao F; Li J; Yao M; Cong W; He X
Cell Death Dis; 2018 Jan; 9(2):59. PubMed ID: 29352111
[TBL] [Abstract][Full Text] [Related]
2. Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma.
Endo M; Yasui K; Zen Y; Gen Y; Zen K; Tsuji K; Dohi O; Mitsuyoshi H; Tanaka S; Taniwaki M; Nakanuma Y; Arii S; Yoshikawa T
Liver Int; 2013 Jan; 33(1):105-17. PubMed ID: 23088494
[TBL] [Abstract][Full Text] [Related]
3. BRG1 promotes hepatocarcinogenesis by regulating proliferation and invasiveness.
Kaufmann B; Wang B; Zhong S; Laschinger M; Patil P; Lu M; Assfalg V; Cheng Z; Friess H; Hüser N; von Figura G; Hartmann D
PLoS One; 2017; 12(7):e0180225. PubMed ID: 28700662
[TBL] [Abstract][Full Text] [Related]
4. Oncogene-dependent function of BRG1 in hepatocarcinogenesis.
Wang P; Song X; Cao D; Cui K; Wang J; Utpatel K; Shang R; Wang H; Che L; Evert M; Zhao K; Calvisi DF; Chen X
Cell Death Dis; 2020 Feb; 11(2):91. PubMed ID: 32019910
[TBL] [Abstract][Full Text] [Related]
5. SMARCA4 (BRG1) activates ABCC3 transcription to promote hepatocellular carcinogenesis.
Liu H; Yue L; Hong W; Zhou J
Life Sci; 2024 Jun; 347():122605. PubMed ID: 38642845
[TBL] [Abstract][Full Text] [Related]
6. High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer.
Guerrero-Martínez JA; Reyes JC
Sci Rep; 2018 Feb; 8(1):2043. PubMed ID: 29391527
[TBL] [Abstract][Full Text] [Related]
7. Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type.
Karnezis AN; Wang Y; Ramos P; Hendricks WP; Oliva E; D'Angelo E; Prat J; Nucci MR; Nielsen TO; Chow C; Leung S; Kommoss F; Kommoss S; Silva A; Ronnett BM; Rabban JT; Bowtell DD; Weissman BE; Trent JM; Gilks CB; Huntsman DG
J Pathol; 2016 Feb; 238(3):389-400. PubMed ID: 26356327
[TBL] [Abstract][Full Text] [Related]
8. A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1.
Oike T; Ogiwara H; Tominaga Y; Ito K; Ando O; Tsuta K; Mizukami T; Shimada Y; Isomura H; Komachi M; Furuta K; Watanabe S; Nakano T; Yokota J; Kohno T
Cancer Res; 2013 Sep; 73(17):5508-18. PubMed ID: 23872584
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer.
Medina PP; Sanchez-Cespedes M
Epigenetics; 2008; 3(2):64-8. PubMed ID: 18437052
[TBL] [Abstract][Full Text] [Related]
10. PES1 is transcriptionally regulated by BRD4 and promotes cell proliferation and glycolysis in hepatocellular carcinoma.
Fan P; Wang B; Meng Z; Zhao J; Jin X
Int J Biochem Cell Biol; 2018 Nov; 104():1-8. PubMed ID: 30172011
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional targets of the chromatin-remodelling factor SMARCA4/BRG1 in lung cancer cells.
Medina PP; Carretero J; Ballestar E; Angulo B; Lopez-Rios F; Esteller M; Sanchez-Cespedes M
Hum Mol Genet; 2005 Apr; 14(7):973-82. PubMed ID: 15731117
[TBL] [Abstract][Full Text] [Related]
12. BET inhibitor suppresses migration of human hepatocellular carcinoma by inhibiting SMARCA4.
Choi HI; An GY; Baek M; Yoo E; Chai JC; Lee YS; Jung KH; Chai YG
Sci Rep; 2021 Jun; 11(1):11799. PubMed ID: 34083693
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of miR-329 promotes cell invasion by regulating BRD4 and predicts poor prognosis in hepatocellular carcinoma.
Zhou J; Li W; Guo J; Li G; Chen F; Zhou J
Tumour Biol; 2016 Mar; 37(3):3561-9. PubMed ID: 26456956
[TBL] [Abstract][Full Text] [Related]
14. BRG1 targeting STAT3/VEGFC signaling regulates lymphangiogenesis in colorectal cancer.
Zhu X; Sun L; Lan J; Xu L; Zhang M; Luo X; Gong J; Wang G; Yuan X; Hu J; Wang J
Oncotarget; 2016 Jun; 7(24):36501-36509. PubMed ID: 27145366
[TBL] [Abstract][Full Text] [Related]
15. BRG1 and BRM SWI/SNF ATPases redundantly maintain cardiomyocyte homeostasis by regulating cardiomyocyte mitophagy and mitochondrial dynamics in vivo.
Bultman SJ; Holley DW; G de Ridder G; Pizzo SV; Sidorova TN; Murray KT; Jensen BC; Wang Z; Bevilacqua A; Chen X; Quintana MT; Tannu M; Rosson GB; Pandya K; Willis MS
Cardiovasc Pathol; 2016; 25(3):258-269. PubMed ID: 27039070
[TBL] [Abstract][Full Text] [Related]
16. Brg1 promotes liver regeneration after partial hepatectomy via regulation of cell cycle.
Wang B; Kaufmann B; Engleitner T; Lu M; Mogler C; Olsavszky V; Öllinger R; Zhong S; Geraud C; Cheng Z; Rad RR; Schmid RM; Friess H; Hüser N; Hartmann D; von Figura G
Sci Rep; 2019 Feb; 9(1):2320. PubMed ID: 30787318
[TBL] [Abstract][Full Text] [Related]
17. Brg1 promotes liver fibrosis via activation of hepatic stellate cells.
Li H; Lan J; Han C; Guo K; Wang G; Hu J; Gong J; Luo X; Cao Z
Exp Cell Res; 2018 Mar; 364(2):191-197. PubMed ID: 29427621
[TBL] [Abstract][Full Text] [Related]
18. The roles of mutated SWI/SNF complexes in the initiation and development of hepatocellular carcinoma and its regulatory effect on the immune system: A review.
Hu B; Lin JZ; Yang XB; Sang XT
Cell Prolif; 2020 Apr; 53(4):e12791. PubMed ID: 32162380
[TBL] [Abstract][Full Text] [Related]
19. BRG1: Promoter or Suppressor of Cancer? The Outcome of BRG1's Interaction with Specific Cellular Pathways.
Shaykevich A; Silverman I; Bandyopadhyaya G; Maitra R
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769189
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers.
Sun A; Tawfik O; Gayed B; Thrasher JB; Hoestje S; Li C; Li B
Prostate; 2007 Feb; 67(2):203-13. PubMed ID: 17075831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
